Drug intelligence / Profile preview

omega-3 fatty acids (Hawler Medical University)

Development stage
Phase 1
Lead developer
BASF
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3 fatty acids are polyunsaturated fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), derived from fish oil. In the context of Sjögren's syndrome, they have been investigated by Hawler Medical University for their anti-inflammatory properties. The mechanism involves modulating prostaglandin metabolism, specifically shifting the balance toward the synthesis of anti-inflammatory prostaglandins and inhibiting the production of pro-inflammatory mediators. A Phase 2/3 clinical trial (NCT05005806) conducted at Rizgary Teaching Hospital in Erbil, Iraq, demonstrated that dietary omega-3 supplementation significantly improved dry eye and dry mouth symptoms and led to the normalization of salivary flow rates in patients with Sjögren's syndrome over a two-month treatment period.

Other names
fish oileicosapentaenoic aciddocosahexaenoic acidEPADHAn-3 polyunsaturated fatty acidsn3 polyunsaturated fatty acidsn 3 polyunsaturated fatty acids
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PTGES (Microsomal prostaglandin E synthase-1)mPGES-2 (Microsomal prostaglandin E synthase-2)ALOX5 (Arachidonate 5-lipoxygenase)COX

Beyond the preview

Go deeper on omega-3 fatty acids (Hawler Medical University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3 fatty acids (Hawler Medical University).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call